Core Viewpoint - Anji Foods has received regulatory scrutiny from the Fujian Securities Regulatory Bureau due to non-compliance in accounting practices and fundraising usage, which includes improper revenue recognition and misclassification of expenses [2] Company Overview - Anji Foods was established on September 28, 1995, with a registered capital of 235.2 million RMB, and is primarily engaged in the research, production, and sales of condiments [3] - The company is led by Chairman Lin Xiaofang and has a workforce of 311 employees [3] Financial Performance - The company's revenue for the years 2022, 2023, 2024, and the first three quarters of 2025 were 557 million RMB, 632 million RMB, 607 million RMB, and 467 million RMB, reflecting year-on-year growth rates of 1.50%, 13.45%, -4.06%, and 3.00% respectively [4] - The net profit attributable to the parent company for the same periods were 13.84 million RMB, 31.09 million RMB, 38.33 million RMB, and 23.22 million RMB, with year-on-year growth rates of -69.51%, 124.73%, 23.29%, and 8.95% respectively [4] - The company's asset-liability ratios for the same periods were 14.35%, 11.27%, 6.36%, and 5.40% [4] Regulatory Actions - The Fujian Securities Regulatory Bureau has mandated corrective actions for Anji Foods, including a requirement for the company and its executives to submit a rectification report within a specified timeframe [2]

Core Viewpoint - Anji Food (603696) has received a decision from the Fujian Regulatory Bureau of the China Securities Regulatory Commission, which mandates corrective measures due to non-compliance in accounting practices and improper use of raised funds [1] Group 1: Regulatory Actions - The company was found to have irregular accounting practices in its trade operations for 2023 and 2024, specifically using the gross method to recognize revenue, which violates accounting standards [1] - The Fujian Regulatory Bureau has imposed administrative measures requiring the company to rectify these issues and has conducted regulatory talks with key executives, including the Chairman, General Manager, and Chief Financial Officer [1] Group 2: Management Response - The company has committed to learning from this incident, reflecting on its practices, and implementing corrective actions to enhance compliance with relevant laws and regulations [1] - Anji Food plans to improve its financial accounting standards to prevent similar violations in the future [1]

Core Viewpoint - Anji Food has received a regulatory decision from the Fujian Securities Regulatory Bureau regarding non-compliance in accounting practices and improper use of raised funds [1] Group 1: Regulatory Actions - The company was found to have non-standard accounting practices in its trade operations for 2023 and 2024, specifically using the gross method to recognize revenue, which violates accounting standards [1] - The Fujian Securities Regulatory Bureau has mandated corrective actions and conducted regulatory talks with key executives, including the Chairman, General Manager, and Chief Financial Officer [1] - The executives involved will have their discussions recorded in the securities and futures market integrity database [1] Group 2: Company Response - The company has committed to learning from this incident, reflecting deeply on the issues, and implementing corrective measures to enhance compliance with laws and regulations [1] - There is a focus on improving financial accounting standards to prevent similar violations in the future [1]

Core Points - The company received a decision from the Fujian Securities Regulatory Bureau regarding corrective measures due to accounting irregularities and improper use of raised funds [1][2] Group 1: Accounting Irregularities - The company improperly recognized revenue for certain trading activities using the gross method, which does not comply with the relevant provisions of the Accounting Standards for Enterprises [1] - The company recorded cash red envelope payments to consumers as sales expenses, violating the relevant provisions of the Accounting Standards for Enterprises [1] - The company failed to timely transfer the construction project of the Shanghai R&D center to fixed asset accounting, resulting in unrecognized depreciation expenses [1] Group 2: Improper Use of Raised Funds - The company continued to use its own funds for project expenditures even after the raised funds were received, which is against the regulatory requirements for the management and use of raised funds [1] Group 3: Accountability - The chairman, general manager, and financial director of the company are held primarily responsible for the aforementioned violations due to their failure to perform due diligence [2]

Core Viewpoint - Shenzhen Yingshisheng Information Technology Co., Ltd. received an administrative regulatory decision from the Shenzhen Securities Regulatory Bureau due to multiple accounting issues affecting the accuracy of financial disclosures [1][3] Group 1: Regulatory Issues - The company was found to have non-compliance in revenue recognition, inadequate impairment assessment for long-term equity investments, improper accounting for other non-current financial assets, and insufficient provision for bad debts on accounts receivable [2][3] - The Shenzhen Securities Regulatory Bureau mandated corrective measures and issued warning letters to the company's chairman, general manager, and CFO [1][3] Group 2: Financial Performance - For the first three quarters of 2025, the company reported revenue of 937 million yuan, a year-on-year decrease of 5.18%, and a net loss attributable to shareholders of 43.21 million yuan, a decline of 210.75% [4] - The basic earnings per share for the period was -0.06 yuan, with a weighted average return on equity of -1.70% [5] - The gross margin for the first three quarters was 42.96%, down 1.28 percentage points year-on-year, while the net margin was -5.01%, a decrease of 3.13 percentage points compared to the previous year [5] Group 3: Cost and Shareholder Information - The company's operating expenses for the period were 438 million yuan, an increase of 4.84 million yuan year-on-year, with an expense ratio of 46.82%, up 2.92 percentage points [6] - As of the end of the third quarter of 2025, the total number of shareholders was 112,400, a decrease of 17,700 from the previous half-year, representing a decline of 13.60% [6]

Core Viewpoint - The company has issued a supplementary announcement regarding the rectification report, addressing revenue misstatements in its financial disclosures from 2021 to 2023, and outlining corrective measures taken to ensure compliance with accounting standards [2][4]. Summary by Sections Rectification Measures - The company's wholly-owned subsidiary, SAIC Hongyan, has reviewed historical sales revenue and strengthened contract reviews to ensure clear and precise accounting treatment [2]. - SAIC Hongyan has improved internal management processes related to product returns, emphasizing the need for clarity in accounting treatment [3]. - For the fiscal year 2024, SAIC Hongyan will recognize domestic sales revenue upon delivery and signing by the customer, with contracts revised accordingly for 2025 [3]. Revenue Adjustments - Adjustments to revenue include a reduction of 1,506,283.19 yuan for 2019, an increase of 769,911.50 yuan for 2020, a reduction of 2,993,097.35 yuan for 2021, a reduction of 647,168.14 yuan for 2022, and an increase of 1,414,955.75 yuan for 2023 [4]. - The impact of these adjustments on reported revenues for the years 2019 to 2023 is less than 0.02%, indicating no significant accounting errors [4]. Financial Management Improvements - The finance department has organized training on accounting standards, particularly focusing on revenue recognition, to enhance compliance and accuracy in financial reporting [4]. - SAIC Hongyan plans to integrate financial and operational departments to improve communication and ensure accurate accounting practices [5]. - Following a court ruling on July 18, 2025, SAIC Hongyan has entered bankruptcy reorganization, with appointed managers overseeing the process to enhance internal management and operational standards [5].

Core Viewpoint - Tianyu Biotechnology Co., Ltd. has announced that it has not faced any penalties from regulatory authorities or exchanges in the past five years, while also detailing the measures taken in response to previous regulatory actions against its controlling shareholder and a subsidiary [1][2][4]. Recent Regulatory Actions and Rectification - The company’s controlling shareholder, Luo Weiguo, received a public reprimand from the Shanghai Stock Exchange for failing to disclose changes in shareholding timely, which resulted from a dilution of shares due to a non-public stock issuance [2]. - The company was subject to administrative regulatory measures by the China Securities Regulatory Commission (CSRC) for inadequate impairment provisions related to a long-term equity investment, which violated accounting standards [2][4]. - The company has established a special rectification working group to address the issues, ensuring compliance with accounting standards and improving governance structures [3][4]. - The former financial director, Sun Weidong, received a regulatory warning for inaccuracies in financial disclosures and has since resigned from his position [4]. - The company has confirmed that its current directors and senior management have not faced any administrative penalties from the CSRC in the last three years [5].

Core Viewpoint - LiuZhou Chemical Co., Ltd. received a corrective order from the Guangxi Securities Regulatory Bureau, requiring the company to rectify identified issues within 30 days and submit a report on the corrective actions taken [1]. Summary by Sections Issues Identified and Corrective Measures - The company acknowledged issues related to non-compliance in accounting practices, specifically inaccurate revenue and cost recognition in financial reports, violating the "Management Measures for Information Disclosure of Listed Companies" [1]. - Corrective actions include adjusting previous accounting errors by changing the revenue recognition method from gross to net, with restated financial statements disclosed [2]. - The impact of the adjustments on financial statements includes a reduction in operating revenue and costs across multiple reporting periods, with specific figures provided for each period [2][3]. Completion of Rectification - The company has completed the necessary corrections and will continue to enhance the quality of financial reporting to prevent similar issues in the future [3]. - The responsible parties for the rectification include the Chairman, General Manager, Board Secretary, and Financial Officer [3]. Compliance with Regulatory Requirements - The company has fulfilled its obligation to check the integrity records of its appointed directors and senior management, addressing previous lapses in compliance [4]. - The company emphasizes ongoing adherence to relevant laws and regulations, aiming to improve governance and internal control processes [4]. Future Plans and Continuous Improvement - The company views the regulatory inspection as an opportunity to enhance operational standards and financial accounting practices [4]. - Future initiatives include regular internal audits, risk assessments, and ensuring compliance with securities market laws to safeguard shareholder interests and promote sustainable development [4].

Core Viewpoint - Huasheng Technology (SZ000790) has received an administrative regulatory decision from the Sichuan Securities Regulatory Bureau due to various accounting and internal control issues, leading to a requirement for corrective measures and warnings issued to key executives [2][4][5]. Group 1: Accounting Issues - The company has been found to have irregular accounting practices, including misclassification of advertising expenses as intangible assets by its subsidiary Hainan Rongsheng Hong Technology Co., Ltd. in 2021 [2]. - In 2023, another subsidiary, Tibet Kangyu Pharmaceutical Co., Ltd., recognized revenue from medical device sales without actual transfer of control to customers, leading to subsequent returns [2]. - Additionally, sales expenses from Chengdu Yuanhong Mineral Water Co., Ltd. were incorrectly accounted for in other subsidiaries, affecting performance assessment accuracy [2]. Group 2: Non-operational Fund Occupation - In 2021, Hainan Huasheng Development Holding Co., Ltd., a subsidiary, prepaid non-main business contract funds, which were later returned after five months, during which some funds flowed into companies controlled by the actual controller, constituting non-operational fund occupation [3]. Group 3: Internal Control Deficiencies - The internal control systems of the subsidiaries are inadequate, with issues such as improper expense reimbursement documentation and non-compliance with procurement management protocols [3]. - The company lacks a robust internal control system for large non-main business expenditures, leading to non-operational fund occupation in 2021 [3]. Group 4: Executive Accountability - Key executives, including Huang Mingliang (Chairman and President), Li Jun (Vice President and CFO), and Song Gang (Vice President), have been held responsible for the identified accounting and internal control issues [4][5]. Group 5: Company Performance - In 2024, Huasheng Technology reported revenue of 864 million yuan, a year-on-year decrease of 13.89%, and a net profit attributable to shareholders of -6.69 million yuan, down 124.19% [8]. - In the first quarter of 2025, the company achieved revenue of 127 million yuan, a decline of 29.21%, with a net profit of -14.59 million yuan, a drop of 740.09% year-on-year [9].

Core Viewpoint - Ruida Futures has received regulatory warnings and penalties from the Xiamen Securities Regulatory Bureau due to accounting irregularities related to revenue recognition, which have led to inaccurate financial disclosures [2][4][5]. Group 1: Regulatory Actions - The Xiamen Securities Regulatory Bureau issued a warning letter to Ruida Futures and mandated disciplinary actions against responsible personnel, including the chairman, general manager, CFO, and chief risk officer [2][4]. - The regulatory measures include increased internal compliance checks and recording the situation in the securities market integrity archives [4][5]. Group 2: Accounting Issues - Ruida Futures' subsidiary, Ruida New Control Capital Management Co., Ltd., was found to have non-compliant accounting practices, specifically regarding revenue recognition for certain trade-related business activities [4]. - The company has corrected prior accounting errors in accordance with relevant accounting standards and has fulfilled its information disclosure obligations [5]. Group 3: Financial Impact - As a result of the accounting issues, Ruida Futures adjusted its revenue recognition method for 2022, leading to a decrease in reported revenue by 77.21 million yuan, revising it to 2.029 billion yuan [5]. - The company reported a significant increase in revenue for 2024, achieving 1.81 billion yuan, a year-on-year growth of 95.45%, and a net profit of 383 million yuan, up 56.93% [6].